Axogen (AXGN) CFO nets shares from 9,000 RSU vesting as company withholds stock for taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Axogen, Inc. CFO Lindsey Marie Hartley reported routine equity compensation activity tied to restricted stock units (RSUs) vesting on March 16, 2026. She exercised RSUs covering 9,000 shares of common stock, consistent with the plan that each RSU delivers one share when it vests.
To satisfy tax withholding obligations, the issuer withheld 3,542 shares of common stock at $32.84 per share rather than executing any open-market sale. After these RSU conversions and tax withholdings, Hartley holds 60,734 shares of Axogen common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
9,000 shares exercised/converted
Mixed
6 txns
Insider
Hartley Lindsey Marie
Role
CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 4,000 | $0.00 | -- |
| Exercise | Restricted Stock Units | 5,000 | $0.00 | -- |
| Exercise | Common Stock | 4,000 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,574 | $32.84 | $52K |
| Exercise | Common Stock | 5,000 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,968 | $32.84 | $65K |
Holdings After Transaction:
Restricted Stock Units — 4,000 shares (Direct);
Common Stock — 59,276 shares (Direct)
Footnotes (1)
- This reflects the number of restricted stock units ("RSUs") that vested on March 16, 2026. This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent an open market sale. Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting date. All shares of Axogen Inc. common stock underlying the restricted stock units are fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vested each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting date.
FAQ
What did Axogen (AXGN) CFO Lindsey Marie Hartley report on this Form 4?
Lindsey Marie Hartley reported RSU vesting and related share movements. She exercised restricted stock units into 9,000 Axogen common shares and had 3,542 of those shares withheld by the company to cover tax obligations, leaving her with 60,734 shares held directly after these transactions.
What are the vesting terms for the Axogen (AXGN) restricted stock units in this filing?
The RSUs vest over a four-year schedule from the grant date. One grant fully vested by March 16, 2026, and another is scheduled to be fully vested by March 16, 2027, with 50% vesting after 24 months and 25% vesting in each of the next two years.
How does Axogen (AXGN) satisfy tax obligations on the CFO’s RSU vesting?
Axogen covers tax obligations by withholding vested shares. In this filing, 3,542 shares of common stock were withheld at a price of $32.84 per share to meet tax withholding and remittance requirements, instead of the CFO selling shares on the open market.